Kyntra Bio (KYNB) Other Non Operating Income (2014 - 2025)
Kyntra Bio (KYNB) posted Other Non Operating Income of $12.2 million for Q4 2025, up 284.71% sequentially from -$6.6 million in Q3 2025.
Kyntra Bio (KYNB) Other Non Operating Income (2014 - 2025) Analysis & Trends
Kyntra Bio has reported Other Non Operating Income for 3 years, with the latest figure at $12.2 million in Q4 2025.
- Quarterly Other Non Operating Income changed N/A year-over-year to $12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (up 158.24% YoY) and the FY2025 annual result came in at $5.6 million, changed N/A from the prior year.
- Other Non Operating Income advanced to $12.2 million in Q4 2025 per KYNB's latest filing, from -$6.6 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $12.2 million in Q4 2025 and troughed at -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.19 Mn |
| Sep 30, 2025 | -6.60 Mn |
| Sep 30, 2015 | 1.46 Mn |
| Jun 30, 2015 | 707,000.00 |
| Mar 31, 2015 | 843,000.00 |
| Sep 30, 2014 | 283,000.00 |
| Jun 30, 2014 | 383,000.00 |
| Mar 31, 2014 | 692,000.00 |